In recent years, several global and local guidelines, recommendations and proposals on chronic obstructive pulmonary disease (COPD) management have been published [1–14]. They illustrate the great interest in this disease that, although no cure exists, is no longer considered untreatable. They also reflect its major and growing burden from both public health and individual perspectives. Finally, they parallel the increasing knowledge of its pathophysiology, clinical characteristics and natural history, as well as of treatment effects, with the goal of personalising care as much as possible. Here, we aim to present recent proposals of the French-Language Respiratory Society (Société de Pneumologie de Langue Française (SPLF)) and put them in perspective with the similarly recent Global Initiative for Chronic Obstructive Lung Disease (GOLD) document, which represents a major revision of GOLD proposals. It is also crucial to take this opportunity to emphasise here that the story of a guideline does not end with its production: the implementation phase is even more important and truly never ends until the next guideline, resulting in an endless cycle. Local adaptations of global recommendations on COPD may be necessary to facilitate appropriation and implementation http://ow.ly/wgNE30eONaG

中文翻译：

---

稳定COPD的药物治疗优化：一个永无止境的故事？

近年来，关于慢性阻塞性肺疾病 (COPD) 管理的一些全球和地方指南、建议和提议已经发表 [1-14]。它们说明了人们对这种疾病的极大兴趣，尽管没有治愈方法，但不再被认为是无法治愈的。它们还从公共卫生和个人的角度反映了其主要且不断增加的负担。最后，他们同时增加对其病理生理学、临床特征和自然病程以及治疗效果的了解，以尽可能实现个性化护理。在这里，我们的目标是介绍法语呼吸学会 (Société de Pneumologie de Langue Française (SPLF)) 的最新提案，并将它们与最近类似的慢性阻塞性肺疾病全球倡议 (GOLD) 文件结合起来，这代表了 GOLD 提案的重大修订。借此机会在此强调一个指南的故事并不会随着它的产生而结束也很重要：实施阶段更为重要，真正直到下一个指南才结束，从而导致无休止的循环。可能需要对 COPD 全球建议进行本地调整，以促进拨款和实施 http://ow.ly/wgNE30eONaG